Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Digital Health|January 27, 2025
Development and implementation of a digiphysical screening model with nationwide reach to diagnose familial hypercholesterolemiaKarin Littmann, Gustav Kindborg, Matthias Lidin, et al.
Diabetes & Vascular Disease Research|July 12, 2018
Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohortViveca Ritsinger, Kerstin Brismar, Linda Mellbin, et al.
Open Heart|November 17, 2015
Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-studyCamilla Hage, Lars H Lund, Erwan Donal, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 19, 2015
Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivityLisa Arnetz, Camilla Hage, Neda Rajamand Ekberg, et al.
Cardiology Research and Practice|January 5, 2024
Enhanced External Counterpulsation for Management of Postacute Sequelae of SARS-CoV-2 Associated Microvascular Angina and Fatigue: An Interventional Pilot StudyEline Wu, Ali Mahdi, Jannike Nickander, et al.
Diabetes Care|February 22, 2020
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE VGiulia Ferrannini, Dirk De Bacquer, Guy De Backer, et al.
Cardiovascular Diabetology|January 13, 2024
Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic statesAlessia Riccio, Elena Fortin, Linda Mellbin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 31, 2023
Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus ComparatorsKathleen M Dungan, Lars Bardtrum, Erik Christiansen, et al.
European Journal of Preventive Cardiology|April 3, 2014
Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional studyViveca Gyberg, Kornelia Kotseva, Jean Dallongeville, et al.
Cardiovascular Diabetology|September 23, 2022
Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control studyElena Fortin, Giulia Ferrannini, Beatrice Campi, et al.
Pageof 7